Novartis Loses AstraZeneca Inhaler Branding TM Challenge
A European court has shot down Swiss pharma giant Novartis' bid to revive its opposition to two AstraZeneca trademarks for its Breztri line of inhalers used to treat bronchitis and emphysema....To view the full article, register now.
Already a subscriber? Click here to view full article